Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Plant extracts >  2-ATRACTYLENOLIDE

2-ATRACTYLENOLIDE

Basic information Safety Supplier Related

2-ATRACTYLENOLIDE Basic information

Product Name:
2-ATRACTYLENOLIDE
Synonyms:
  • ASTEROLIDE
  • 2-ATRACTYLENOLIDE
  • Atractylenolide II (Asterolide)
  • (4aS,8aR,9aS)-4a,5,6,7,8,8a,9,9a-Octahydro-3,8a-dimethyl-5-methylenenaphtho[2,3-b]furan-2(4H)-one
  • Atractylenolide Ⅱ
  • Atractylenolide II, BR
  • Atracylenolide II
  • Naphtho[2,3-b]furan-2(4H)-one, 4a,5,6,7,8,8a,9,9a-octahydro-3,8a-dimethyl-5-methylene-, (4aS,8aR,9aS)-
CAS:
73069-14-4
MF:
C15H20O2
MW:
232.32
Product Categories:
  • chemical reagent
  • pharmaceutical intermediate
  • phytochemical
  • reference standards from Chinese medicinal herbs (TCM).
  • standardized herbal extract
Mol File:
73069-14-4.mol
More
Less

2-ATRACTYLENOLIDE Chemical Properties

Melting point:
150-152 °C(Solv: ethyl ether (60-29-7))
Boiling point:
378.0±41.0 °C(Predicted)
Density 
1.09±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
Soluble in chloroform
form 
powder
color 
White
More
Less

2-ATRACTYLENOLIDE Usage And Synthesis

Chemical Properties

White crystalline powder, soluble in organic solvents such as methanol, ethanol, and DMSO. It is derived from Atractylodes macrocephala Koidz.

Uses

food and beverages

Definition

ChEBI: Atractylenolide II is a sesquiterpene lactone.

in vivo

Atractylenolide II (12.5-25 mg/kg; Oral gavage; 14 days) has antitumor effect in a B16 xenograft mouse model[3].
Atractylenolide II (10-60 mg/kg/d; Intraperitoneal injection; 8 weeks) improves myocardial fibrosis and oxidative stress in spontaneously hypertensive rats[4].

Animal Model:C57/BL6 mice with a B16 xenograft model[3]
Dosage:12.5 and 25 mg/kg
Administration:Oral gavage (i.g.); 14 days
Result:Significantly inhibited tumor growth.
Inhibited the activation/phosphorylation of STAT3 and Src.
Animal Model:Spontaneous hypertension rats[4]
Dosage:10, 30 and 60 mg/kg/d
Administration:Intraperitoneal injection (i.p.); 8 weeks
Result:Improved the body weight of spontaneous hypertension rats and enhanced myocardial function in a dose-dependent manner.
Effectively reduced cardiomyocyte apoptosis.
Inhibited the Collagen I, α-SMA, Fibronectin and Vimentin mRNA and protein expression levels.
Ameliorated oxidative stress by improving the activities of SOD and GSH-PX and lowering the contents of H2O2 and MDA, which reached about 80%.

IC 50

p-STAT3

2-ATRACTYLENOLIDESupplier

Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
Shandong Xiya Chemical Co., Ltd
Tel
4009903999 13355009207
Email
3007715519@qq.com
China Langchem Inc.
Tel
0086-21-58956006
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com